ICU Medical Inc. (ICUI)
ICU Medical Inc. (ICUI) Stock Price, Analysis & Data
| Bid | 135.29 |
| Market Cap | 4.68B |
| Revenue (ttm) | 2.16B |
| Net Income (ttm) | 30.09M |
| Beta | 0.75 |
| EPS (ttm) | 1.19 |
| PE Ratio (ttm) | 157.36 |
| Forward PE | 19.41 |
| P/B (ttm) | 2.18 |
| P/S (ttm) | 2.17 |
| Earnings Date | Nov 5, 2026 |
| Ask | 237.12 |
| Volume | 109,697 |
| Avg. Volume (20D) | 318,572 |
| Open | 185.82 |
| Previous Close | 183.76 |
| Day's Range | 185.65 - 189.29 |
| 52-Week Range | 112.50 - 192.85 |
| Analyst | Buy |
| Price Target | 192.5 (2.96%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free conn...
Financial Performance
In 2025, ICU Medical's revenue was 2.23B, a decrease of -6.33% compared to the previous year's 2.38B. Earnings were 732K, a decrease of -100.62%.
Financial StatementsAnalyst Forecast
According to 8 analyst ratings, the average rating for ICUI stock is "Buy". The 12-month stock price forecast is 192.5, which is upside of 2.96% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
